A pilot study of a mixed-method approach to design an ED-based peer mHealth referral tool for HIV/HCV and opioid overdose prevention services.

[1]  M. Alavi,et al.  Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment. , 2022, Drug and alcohol dependence.

[2]  R. Urman,et al.  Opioid Use Disorder and Racial/Ethnic Health Disparities: Prevention and Management , 2022, Current Pain and Headache Reports.

[3]  Andrea C. Radick,et al.  Video directly observed therapy for patients receiving office-based buprenorphine - A pilot randomized controlled trial. , 2021, Drug and alcohol dependence.

[4]  Caroline R. Scherzer,et al.  Feasibility and acceptability of a digital health intervention to promote engagement in and adherence to medication for opioid use disorder. , 2021, Journal of substance abuse treatment.

[5]  M. Winston,et al.  The perspectives of people who use drugs regarding short term involuntary substance use care for severe substance use disorders. , 2021, The International journal on drug policy.

[6]  Andrea J. Yatsco,et al.  Prevalence and charges of opioid-related visits to U.S. emergency departments. , 2021, Drug and alcohol dependence.

[7]  M. Lyons,et al.  Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatment. , 2020, Drug and alcohol dependence.

[8]  C. Grov,et al.  PrEP uptake as a social movement among gay and bisexual men , 2020, Culture, health & sexuality.

[9]  S. Schenkel,et al.  Access and Barriers to Take-Home Naloxone Use among Emergency Department Patients with Opioid Misuse in Baltimore, Maryland, USA , 2020, Substance use & misuse.

[10]  D. White,et al.  High prevalence of injection drug use and blood-borne viral infections among patients in an urban emergency department , 2020, PloS one.

[11]  N. Volkow,et al.  America’s opioid crisis: the need for an integrated public health approach , 2020, Translational Psychiatry.

[12]  Megan L. Ranney,et al.  Mobile Peer-Support for Opioid Use Disorders: Refinement of an Innovative Machine Learning Tool , 2020, Journal of psychiatry and brain science.

[13]  D. Hien,et al.  Perspectives on trauma and the design of a technology-based trauma-informed intervention for women receiving medications for addiction treatment in community-based settings. , 2020, Journal of substance abuse treatment.

[14]  A. Mcgregor,et al.  What is the clinical value of mHealth for patients? , 2020, npj Digital Medicine.

[15]  Stephen E. Lankenau,et al.  Acceptability of smartphone applications for facilitating layperson naloxone administration during opioid overdoses , 2019, JAMIA open.

[16]  S. Mehta,et al.  Recent fentanyl use among people who inject drugs: Results from a rapid assessment in Baltimore, Maryland. , 2019, The International journal on drug policy.

[17]  Kim A. Hoffman,et al.  Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial , 2019, BMC Health Services Research.

[18]  C. Kuziemsky,et al.  Using Patient and Family Engagement Strategies to Improve Outcomes of Health Information Technology Initiatives: Scoping Review , 2019, Journal of medical Internet research.

[19]  R. Moss,et al.  Higher doses of naloxone are needed in the synthetic opiod era , 2019, Substance Abuse Treatment, Prevention, and Policy.

[20]  Jagpreet Chhatwal,et al.  Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States , 2019, JAMA network open.

[21]  M. Brizzi,et al.  Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review , 2019, Infectious Diseases and Therapy.

[22]  Mark P. MacEachern,et al.  The Emergency Department as an Opportunity for Naloxone Distribution , 2018, The western journal of emergency medicine.

[23]  G. Badger,et al.  A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study. , 2018, Drug and alcohol dependence.

[24]  Y. Hsieh,et al.  Emergency departments at the crossroads of intersecting epidemics (HIV, HCV, injection drug use and opioid overdose)—Estimating HCV incidence in an urban emergency department population , 2018, Journal of viral hepatitis.

[25]  D. Houry,et al.  Opportunities for Prevention and Intervention of Opioid Overdose in the Emergency Department. , 2018, Annals of emergency medicine.

[26]  Megha L Mehrotra,et al.  The Role of Social Relationships in PrEP Uptake and Use Among Transgender Women and Men Who Have Sex with Men , 2018, AIDS and Behavior.

[27]  S. Wakeman,et al.  Emergency Department Treatment of Opioid Addiction: An Opportunity to Lead. , 2018, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[28]  Mary E Hawk,et al.  Effects of naloxone distribution to likely bystanders: Results of an agent-based model. , 2018, The International journal on drug policy.

[29]  M. Fingerhood,et al.  Overcoming Medication Stigma in Peer Recovery: A New Paradigm , 2018, Substance abuse.

[30]  Henry E. Wang,et al.  Continuum of Care for Hepatitis C Virus Among Patients Diagnosed in the Emergency Department Setting , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  S. Allen,et al.  Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility , 2017, Harm Reduction Journal.

[32]  G. D’Onofrio,et al.  Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention , 2017, Journal of General Internal Medicine.

[33]  S. Young,et al.  The Harnessing Online Peer Education (HOPE) intervention for reducing prescription drug abuse: A qualitative study , 2017, Journal of substance use.

[34]  Henry E. Wang,et al.  Characterizing Failure to Establish Hepatitis C Care of Baby Boomers Diagnosed in the Emergency Department , 2016, Open forum infectious diseases.

[35]  O. Laeyendecker,et al.  Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  O. Laeyendecker,et al.  Improvements in the continuum of HIV care in an inner-city emergency department , 2016, AIDS.

[37]  S. Sismondo.  How to make opinion leaders and influence people , 2015, Canadian Medical Association Journal.

[38]  Charles J DiMaggio,et al.  Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis , 2015, Injury Epidemiology.

[39]  Eric J. Topol,et al.  The emerging field of mobile health , 2015, Science Translational Medicine.

[40]  M. Hillhouse,et al.  Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study , 2015, Journal of Community Health.

[41]  M. Loutfy,et al.  A scoping review and thematic analysis of social and behavioural research among HIV-serodiscordant couples in high-income settings , 2015, BMC Public Health.

[42]  H. Wand,et al.  A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. , 2013, Preventive medicine.

[43]  Al Ozonoff,et al.  Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis , 2013, BMJ.

[44]  D. Blazer,et al.  Alcohol and drug use disorders among adults in emergency department settings in the United States. , 2012, Annals of emergency medicine.

[45]  N. Leech,et al.  A Qualitative Framework for Collecting and Analyzing Data in Focus Group Research , 2009 .

[46]  M. Alary,et al.  Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up. , 2019, Gates open research.